<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39377138</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Epidemiology and infection</Title><ISOAbbreviation>Epidemiol Infect</ISOAbbreviation></Journal><ArticleTitle>Superspreading of SARS-CoV-2: a systematic review and meta-analysis of event attack rates and individual transmission patterns.</ArticleTitle><Pagination><StartPage>e121</StartPage><MedlinePgn>e121</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e121</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268824000955</ELocationID><Abstract><AbstractText>SARS-CoV-2 superspreading occurs when transmission is highly efficient and/or an individual infects many others, contributing to rapid spread. To better quantify heterogeneity in SARS-CoV-2 transmission, particularly superspreading, we performed a systematic review of transmission events with data on secondary attack rates or contact tracing of individual index cases published before September 2021 prior to the emergence of variants of concern and widespread vaccination. We reviewed 592 distinct events and 9,883 index cases from 491 papers. A meta-analysis of secondary attack rates identified substantial heterogeneity across 12 chosen event types/settings, with the highest transmission (25-35%) in co-living situations including households, nursing homes, and other congregate housing. Among index cases, 67% reported zero secondary cases and only 3% (287) infected &gt;5 secondary cases ("superspreaders"). Index case demographic data were limited, with only 55% of individuals reporting age, sex, symptoms, real-time polymerase chain reaction (PCR) cycle threshold values, or total contacts. With the data available, we identified a higher percentage of superspreaders among symptomatic individuals, individuals aged 49-64 years, and individuals with over 100 total contacts. Addressing gaps in the literature regarding transmission events and contact tracing is needed to properly explain the heterogeneity in transmission and facilitate control efforts for SARS-CoV-2 and other infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McKee</LastName><ForeName>Clifton D</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0002-6149-0598</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Emma X</ForeName><Initials>EX</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Andrés</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Jules</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koyuncu</LastName><ForeName>Aybüke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rose</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azman</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0001-8662-9077</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobner</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Welch Medical Library, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacks</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Kerkhove</LastName><ForeName>Maria D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Epidemic and Pandemic Preparedness and Prevention, Emergency Preparedness Programme, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurley</LastName><ForeName>Emily S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Infect</MedlineTA><NlmUniqueID>8703737</NlmUniqueID><ISSNLinking>0950-2688</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016358" MajorTopicYN="Y">Contact Tracing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">heterogeneity</Keyword><Keyword MajorTopicYN="N">infectious disease epidemiology</Keyword><Keyword MajorTopicYN="N">transmission</Keyword></KeywordList><CoiStatement>The authors declare none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>7</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39377138</ArticleId><ArticleId IdType="pmc">PMC11488467</ArticleId><ArticleId IdType="doi">10.1017/S0950268824000955</ArticleId><ArticleId IdType="pii">S0950268824000955</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis JT, et al. (2021) Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. Nature 600, 127–132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8636257</ArticleId><ArticleId IdType="pubmed">34695837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau MSY, et al. (2020) Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proceedings of the National Academy of Sciences 117, 22430–22435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486752</ArticleId><ArticleId IdType="pubmed">32820074</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam DC, et al. (2020) Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nature Medicine 26, 1714–1719.</Citation><ArticleIdList><ArticleId IdType="pubmed">32943787</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Eggo RM and Kucharski AJ (2020) Secondary attack rate and superspreading events for SARS-CoV-2. The Lancet 395, e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158947</ArticleId><ArticleId IdType="pubmed">32113505</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakdawala SS and Menachery VD (2021) Catch me if you can: Superspreading of COVID-19. Trends in Microbiology 29, 919–929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112283</ArticleId><ArticleId IdType="pubmed">34059436</ArticleId></ArticleIdList></Reference><Reference><Citation>Puhach O, Meyer B and Eckerle I (2023) SARS-CoV-2 viral load and shedding kinetics. Nature Reviews Microbiology 21, 147–161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9716513</ArticleId><ArticleId IdType="pubmed">36460930</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. (2021) Superspreading and heterogeneity in transmission of SARS, MERS, and COVID-19: A systematic review. Computational and Structural Biotechnology Journal 19, 5039–5046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409018</ArticleId><ArticleId IdType="pubmed">34484618</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, et al. (2022) Systematic review and meta-analyses of superspreading of SARS-CoV-2 infections. Transboundary and Emerging Diseases 69, e3007–e3014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349569</ArticleId><ArticleId IdType="pubmed">35799321</ArticleId></ArticleIdList></Reference><Reference><Citation>Althaus CL (2015) Ebola superspreading. The Lancet Infectious Diseases 15, 507–508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158960</ArticleId><ArticleId IdType="pubmed">25932579</ArticleId></ArticleIdList></Reference><Reference><Citation>Paunio M, et al. (1998) Explosive school-based measles outbreak: Intense exposure may have resulted in high risk, even among revaccinees. American Journal of Epidemiology 148, 1103–1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">9850133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Smith JO, et al. (2005) Superspreading and the effect of individual variation on disease emergence. Nature 438, 355–359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094981</ArticleId><ArticleId IdType="pubmed">16292310</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolay B, et al. (2019) Transmission of Nipah virus — 14 years of investigations in Bangladesh. The New England Journal of Medicine 380, 1804–1814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6547369</ArticleId><ArticleId IdType="pubmed">31067370</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis D (2021) Superspreading drives the COVID pandemic — And could help to tame it. Nature 590, 544–546.</Citation><ArticleIdList><ArticleId IdType="pubmed">33623168</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamner L, et al. (2020) High SARS-CoV-2 attack rate following exposure at a choir practice — Skagit County, Washington, march 2020. MMWR. Morbidity and Mortality Weekly Report 69, 606–610.</Citation><ArticleIdList><ArticleId IdType="pubmed">32407303</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EC, et al. (2020) The engines of SARS-CoV-2 spread. Science 370, 406–407.</Citation><ArticleIdList><ArticleId IdType="pubmed">33093098</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson HA, et al. (2021) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) setting-specific transmission rates: A systematic review and meta-analysis. Clinical Infectious Diseases 73, e754–e764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929012</ArticleId><ArticleId IdType="pubmed">33560412</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclerc QJ, et al. (2020) What settings have been linked to SARS-CoV-2 transmission clusters? Wellcome Open Research 5, 83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327724</ArticleId><ArticleId IdType="pubmed">32656368</ArticleId></ArticleIdList></Reference><Reference><Citation>Madewell ZJ, et al. (2021) Factors associated with household transmission of SARS-CoV-2: An updated systematic review and meta-analysis. JAMA Network Open 4, e2122240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8397928</ArticleId><ArticleId IdType="pubmed">34448865</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh WC, et al. (2020) What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PLoS One 15, e0240205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7544065</ArticleId><ArticleId IdType="pubmed">33031427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramírez-del Real T, et al. (2022) Individual factors associated with COVID-19 infection: A machine learning study. Frontiers in Public Health 10, 912099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279686</ArticleId><ArticleId IdType="pubmed">35844896</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M, et al. (2022) Contact tracing of COVID-19 in Karnataka, India: Superspreading and determinants of infectiousness and symptomatic infection. PLoS One 17, e0270789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9273085</ArticleId><ArticleId IdType="pubmed">35816497</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, et al. (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Systematic Reviews 10, 89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodcroft EB (2021) CoVariants: SARS-CoV-2 Mutations and Variants of Interest. Available at https://covariants.org/ (accessed January 18, 2023).</Citation></Reference><Reference><Citation>Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. Journal of Statistical Software 36, 1–48.</Citation></Reference><Reference><Citation>Lin L and Xu C (2020) Arcsine-based transformations for meta-analysis of proportions: Pros, cons, and alternatives. Health Science Reports 3, e178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7384291</ArticleId><ArticleId IdType="pubmed">32728636</ArticleId></ArticleIdList></Reference><Reference><Citation>Senior AM, et al. (2016) Heterogeneity in ecological and evolutionary meta-analyses: Its magnitude and implications. Ecology 97, 3293–3299.</Citation><ArticleIdList><ArticleId IdType="pubmed">27912008</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo A, et al. (2020) Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China. Wellcome Open Research 5, 67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338915</ArticleId><ArticleId IdType="pubmed">32685698</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L, et al. (2021) COVID-19 super spreading event amongst elderly individuals — Jilin Province, China, January 2021. China CDC Weekly 3, 211–213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8392975</ArticleId><ArticleId IdType="pubmed">34594851</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu DKW, et al. (2021) SARS-CoV-2 superspread in fitness center, Hong Kong, China, March 2021. Emerging Infectious Diseases 27, 2230–2232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314845</ArticleId><ArticleId IdType="pubmed">34004137</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PZ, et al. (2021) Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols. eLife 10, e65774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8139838</ArticleId><ArticleId IdType="pubmed">33861198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke R, et al. (2022) Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness. Nature Microbiology 7, 640–652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9084242</ArticleId><ArticleId IdType="pubmed">35484231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, et al. (2023) Viral emissions into the air and environment after SARS-CoV-2 human challenge: A phase 1, open label, first-in-human study. The Lancet Microbe 4, e579–e590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10256269</ArticleId><ArticleId IdType="pubmed">37307844</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegehaupt O, Endo A and Vassall A (2023) Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: A systematic review and meta-analysis of the literature. BMC Public Health 23, 1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10227392</ArticleId><ArticleId IdType="pubmed">37254143</ArticleId></ArticleIdList></Reference><Reference><Citation>Madewell ZJ, et al. (2020) Household transmission of SARS-CoV-2: A systematic review and meta-analysis. JAMA Network Open 3, e2031756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737089</ArticleId><ArticleId IdType="pubmed">33315116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi Q, et al. (2021) Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nature Communications 12, 3643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206123</ArticleId><ArticleId IdType="pubmed">34131124</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi S, et al. (2019) Aerosol emission and superemission during human speech increase with voice loudness. Scientific Reports 9, 2348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382806</ArticleId><ArticleId IdType="pubmed">30787335</ArticleId></ArticleIdList></Reference><Reference><Citation>Mürbe D, et al. (2021) Aerosol emission in professional singing of classical music. Scientific Reports 11, 14861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8295351</ArticleId><ArticleId IdType="pubmed">34290265</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizawa Y, et al. (2021) Coronavirus disease 2019 cluster originating in a primary school teachers’ room in Japan. The Pediatric Infectious Disease Journal 40, e418–e423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505149</ArticleId><ArticleId IdType="pubmed">34561385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gettings JR, et al. (2022) SARS-CoV-2 transmission in a Georgia school district — United States, December 2020–January 2021. Clinical Infectious Diseases 74, 319–326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083290</ArticleId><ArticleId IdType="pubmed">33864375</ArticleId></ArticleIdList></Reference><Reference><Citation>Brainard J, et al. (2023) Super-spreaders of novel coronaviruses that cause SARS, MERS and COVID-19: A systematic review. Annals of Epidemiology 82, 66–76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10208417</ArticleId><ArticleId IdType="pubmed">37001627</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe Covid-19 GWAS Group, et al.. (2020) Genomewide association study of severe Covid-19 with respiratory failure. The New England Journal of Medicine 383, 1522–1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, et al.. (2021) Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clinical Infectious Diseases 73, 328–331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454371</ArticleId><ArticleId IdType="pubmed">32750119</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards DA, et al. (2021) Exhaled aerosol increases with COVID-19 infection, age, and obesity. Proceedings of the National Academy of Sciences 118, e2021830118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7923364</ArticleId><ArticleId IdType="pubmed">33563754</ArticleId></ArticleIdList></Reference><Reference><Citation>Caillard S, et al. (2021) SARS-CoV-2 viral dynamics in immunocompromised patients. American Journal of Transplantation 21, 1667–1669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675471</ArticleId><ArticleId IdType="pubmed">33048424</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydillo T, et al. (2020) Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. New England Journal of Medicine 383, 2586–2588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7722690</ArticleId><ArticleId IdType="pubmed">33259154</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X, et al. (2021) The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—A living systematic review. Clinical Microbiology and Infection 27, 511–519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7825872</ArticleId><ArticleId IdType="pubmed">33484843</ArticleId></ArticleIdList></Reference><Reference><Citation>Buitrago-Garcia D, et al. (2022) Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis. PLoS Medicine 19, e1003987.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9135333</ArticleId><ArticleId IdType="pubmed">35617363</ArticleId></ArticleIdList></Reference><Reference><Citation>James A, et al. (2021) Model-free estimation of COVID-19 transmission dynamics from a complete outbreak. PLoS One 16, e0238800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7990215</ArticleId><ArticleId IdType="pubmed">33760817</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NG, et al. (2020) Age-dependent effects in the transmission and control of COVID-19 epidemics. Nature Medicine 26, 1205–1211.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546824</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>